华测检测今年以来股价涨19.85%，近5个交易日涨6.77%，近20日涨19.24%，近60日涨14.13%。 责任编辑：小浪快报 资料显示，华测检测认证集团股份有限公司位于广东省深圳市宝安区新安街道留仙三路4号华测检测大 楼，成立日期2003年12月23日，上市日期2009年10月30日，公司主营业务涉及贸易保障、消费品检测、 工业品检测和生命科学领域的技术检测服务。主营业务收入构成为：生命科学43.02%，工业测试 20.31%，消费品测试17.64%，贸易保障14.39%，医药及医学服务4.64%。 华测检测所属申万行业为：社会服务-专业服务-检测服务。所属概念板块包括：CDM概念、房屋检测、 养老金持股、半导体等。 截至9月30日，华测检测股东户数7.66万，较上期减少5.62%；人均流通股18698股，较上期增加5.96%。 2025年1月-9月，华测检测实现营业收入47.02亿元，同比增长6.95%；归母净利润8.12亿元，同比增长 8.78%。 分红方面，华测检测A股上市后累计派现11.61亿元。近三年，累计派现5.19亿元。 机构持仓方面，截止2025年9月30日，华测检测十大流通股东中，香港 ...

Core Viewpoint - The company, Zhongjin Ruzhao, plans to raise up to 800 million yuan through a private placement to fund several sterilization technology projects and supplement working capital, with the controlling shareholder, China National Gold Group, participating in the investment [1][2]. Group 1: Fundraising and Investment Projects - Zhongjin Ruzhao intends to issue shares to no more than 35 specific investors, including China National Gold Group, to raise funds for projects including the Changsha Sterilization Technology Service Center and the Hefei Comprehensive Sterilization Technology Center [1][2]. - The total investment for the Changsha and Hefei projects is 400 million yuan, with planned fundraising allocations of 100 million yuan and 200 million yuan respectively, yielding after-tax internal rates of return of 11.35% and 8.51% [2]. - The company also plans to invest 100 million yuan in the second phase of the annual sterilization medical device project at Zhongjin Health Technology (Jiaxing), which has a total investment of 108 million yuan [2]. Group 2: Operational Strategy and Market Position - The company has established a national presence with service areas including Shenzhen, Shanghai, Tianjin, Qingdao, Wuhan, Chengdu, Chongqing, and Jiaxing, aiming to enhance regional connectivity and market share through the new projects [3]. - Zhongjin Ruzhao's main business segments include irradiation technology services, disinfection supply services, and technical testing services, with irradiation technology being the primary source of revenue and profit [3]. - The company has formed long-term strategic partnerships with over 30 Fortune 500 companies, serving various industries such as healthcare, food, pharmaceuticals, daily necessities, and packaging materials [3]. Group 3: Financial Performance - For the first three quarters of 2025, Zhongjin Ruzhao reported revenues of 278 million yuan and a net profit of 89.81 million yuan, reflecting a year-on-year decline of 6.35% [4].

Core Viewpoint - 华测检测's stock price has experienced fluctuations, with a current decline of 2.05% and a year-to-date increase of 12.78% [1] Financial Performance - For the period from January to September 2025, 华测检测 achieved a revenue of 4.702 billion yuan, representing a year-on-year growth of 6.95% [2] - The net profit attributable to shareholders for the same period was 812 million yuan, reflecting an increase of 8.78% year-on-year [2] Shareholder Information - As of September 30, 2025, the number of shareholders for 华测检测 was 76,600, a decrease of 5.62% from the previous period [2] - The average number of circulating shares per shareholder increased by 5.96% to 18,698 shares [2] Dividend Distribution - Since its A-share listing, 华测检测 has distributed a total of 1.161 billion yuan in dividends, with 519 million yuan distributed over the past three years [3] Major Shareholders - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 289 million shares, an increase of 20.82 million shares from the previous period [3] - 易方达创业板ETF and 南方中证500ETF have seen reductions in their holdings, with 易方达创业板ETF holding 29.89 million shares, down by 5.03 million shares [3]

Core Viewpoint - 华测检测's stock price has shown a year-to-date increase of 17.58%, with a recent decline of 2.04% on November 4, 2023, indicating fluctuations in market performance [1] Financial Performance - For the period from January to September 2025, 华测检测 achieved a revenue of 4.702 billion yuan, representing a year-on-year growth of 6.95% [2] - The net profit attributable to shareholders for the same period was 812 million yuan, reflecting an increase of 8.78% compared to the previous year [2] Shareholder Information - As of September 30, 2025, the number of shareholders for 华测检测 was 76,600, a decrease of 5.62% from the previous period [2] - The average number of circulating shares per shareholder increased by 5.96% to 18,698 shares [2] Dividend Distribution - Since its A-share listing, 华测检测 has distributed a total of 1.161 billion yuan in dividends, with 519 million yuan distributed over the last three years [3] Major Shareholders - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 289 million shares, an increase of 20.82 million shares from the previous period [3] - The third-largest shareholder, E Fund Chuangye ETF, holds 29.89 million shares, a decrease of 5.03 million shares [3] - The fourth-largest shareholder, Southern CSI 500 ETF, holds 24.50 million shares, with a reduction of 444,000 shares [3]

Core Viewpoint - 华测检测's stock price has shown a positive trend, with a year-to-date increase of 17.82% and a recent uptick in trading activity, indicating investor interest and potential growth in the company's market position [1][2]. Financial Performance - For the first half of 2025, 华测检测 reported a revenue of 2.96 billion yuan, reflecting a year-on-year growth of 6.05%, while the net profit attributable to shareholders was 467 million yuan, up 7.03% compared to the previous year [2]. - Cumulatively, since its A-share listing, the company has distributed a total of 1.16 billion yuan in dividends, with 519 million yuan distributed over the last three years [3]. Shareholder Structure - As of June 30, 2025, 华测检测 had 81,100 shareholders, an increase of 4.53% from the previous period, with an average of 17,647 circulating shares per shareholder, down 4.34% [2]. - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 269 million shares, which increased by 7.87 million shares from the previous period [3]. Stock Performance - 华测检测's stock price reached 14.47 yuan per share, with a trading volume of 456 million yuan and a turnover rate of 2.25%, leading to a total market capitalization of 24.35 billion yuan [1]. - The stock has experienced a 1.47% increase over the last five trading days, an 11.22% increase over the last 20 days, and a 19.49% increase over the last 60 days [1]. Business Segments - The company's main business segments include life sciences (43.02% of revenue), industrial testing (20.31%), consumer product testing (17.64%), trade assurance (14.39%), and medical services (4.64%) [1].

Core Viewpoint - 华测检测's stock price has shown a modest increase this year, with a notable rise in revenue and net profit for the first half of 2025, indicating a stable growth trajectory in its core business areas [1][2]. Financial Performance - As of June 30, 2025, 华测检测 achieved a revenue of 2.96 billion yuan, representing a year-on-year growth of 6.05% [2]. - The net profit attributable to shareholders for the same period was 467 million yuan, reflecting a year-on-year increase of 7.03% [2]. Stock Market Activity - On October 22, 华测检测's stock price decreased by 2.06%, trading at 14.23 yuan per share with a total market capitalization of 23.947 billion yuan [1]. - The stock has increased by 15.87% year-to-date, with a 0.35% rise over the last five trading days and an 8.96% increase over the last 20 days [1]. Shareholder Information - As of June 30, 2025, the number of shareholders increased to 81,100, up by 4.53% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 4.34% to 17,647 shares [2]. Dividend Distribution - 华测检测 has distributed a total of 1.161 billion yuan in dividends since its A-share listing, with 519 million yuan distributed over the last three years [3]. Major Shareholders - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 269 million shares, an increase of 7.8679 million shares from the previous period [3]. - 易方达创业板ETF and 南方中证500ETF are among the top shareholders, with changes in their holdings noted [3].

Core Insights - Huace Testing's stock increased by 0.56% on October 16, with a trading volume of 920 million yuan, indicating active market participation [1] - The company reported a net financing outflow of 666.36 million yuan on the same day, with a total financing and margin balance of 702 million yuan [1] - As of June 30, Huace Testing achieved a revenue of 2.96 billion yuan for the first half of 2025, reflecting a year-on-year growth of 6.05%, and a net profit of 467 million yuan, up 7.03% [2] Financing and Margin Data - On October 16, Huace Testing had a financing buy-in of 86.64 million yuan, with a current financing balance of 682 million yuan, representing 2.84% of its market capitalization [1] - The company’s financing balance is above the 90th percentile of the past year, indicating a high level of leverage [1] - In terms of margin trading, 4,100 shares were repaid, with a short-selling amount of 34.65 million yuan, and a margin balance of 19.79 million yuan, also above the 90th percentile of the past year [1] Shareholder and Dividend Information - As of June 30, the number of Huace Testing shareholders increased to 81,100, a rise of 4.53%, while the average number of circulating shares per person decreased by 4.34% [2] - The company has distributed a total of 1.161 billion yuan in dividends since its A-share listing, with 519 million yuan distributed over the last three years [3] - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 269 million shares, an increase of 7.8679 million shares compared to the previous period [3]

Core Viewpoint - 华测检测's stock price has experienced fluctuations, with a recent decline of 2.05% and a total market capitalization of 21.725 billion yuan, while the company shows a year-to-date stock price increase of 4.70% [1] Financial Performance - For the first half of 2025, 华测检测 reported revenue of 2.96 billion yuan, reflecting a year-on-year growth of 6.05%, and a net profit attributable to shareholders of 467 million yuan, up 7.03% year-on-year [2] - Cumulative cash dividends since the company's A-share listing amount to 1.077 billion yuan, with 436 million yuan distributed over the past three years [3] Shareholder Structure - As of June 30, 2025, 华测检测 had 81,100 shareholders, an increase of 4.53% from the previous period, with an average of 17,647 circulating shares per shareholder, down 4.34% [2] - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 269 million shares, an increase of 7.8679 million shares from the previous period [3] - Other notable shareholders include 易方达创业板ETF and 南方中证500ETF, with changes in their holdings compared to the previous period [3] Business Segmentation - 华测检测's main business segments include life sciences (43.02%), industrial testing (20.31%), consumer product testing (17.64%), trade assurance (14.39%), and pharmaceutical and medical services (4.64%) [1]

Core Viewpoint - 华测检测's stock price has shown significant growth in recent months, with a year-to-date increase of 15.72% and a 27.18% rise over the past 60 days, indicating strong market performance and investor interest [1]. Financial Performance - For the first half of 2025, 华测检测 reported a revenue of 2.96 billion yuan, representing a year-on-year growth of 6.05%, while the net profit attributable to shareholders was 467 million yuan, up 7.03% compared to the previous year [2]. - Cumulatively, since its A-share listing, 华测检测 has distributed a total of 1.077 billion yuan in dividends, with 436 million yuan distributed over the last three years [3]. Shareholder Structure - As of June 30, 2025, 华测检测 had 81,100 shareholders, an increase of 4.53% from the previous period, with an average of 17,647 circulating shares per shareholder, down 4.34% [2]. - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 269 million shares, which increased by 7.87 million shares from the previous period [3].